{{Rsnum
|rsid=3827886
|Gene=PLBD1
|Chromosome=12
|position=14507250
|Orientation=plus
|GMAF=0.09871
|Gene_s=PLBD1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.5 | 22.1 | 74.3
| HCB | 0.0 | 16.8 | 83.2
| JPT | 2.7 | 23.0 | 74.3
| YRI | 0.0 | 5.4 | 94.6
| ASW | 0.0 | 8.8 | 91.2
| CHB | 0.0 | 16.8 | 83.2
| CHD | 0.0 | 17.4 | 82.6
| GIH | 5.0 | 28.7 | 66.3
| LWK | 0.0 | 1.8 | 98.2
| MEX | 0.0 | 12.1 | 87.9
| MKK | 0.6 | 7.1 | 92.3
| TSI | 2.0 | 20.6 | 77.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=7E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}